Wolters Kluwer data for week 24 shows a w/w increase in market share for Zubsolv tablets by 0.24 percentage points, reaching 6.20%. The four week rolling average reached 6.05%, which were up 0.03 percentage point since last week. Zubsolv TRx market share were up by 0.12 percentage points to 5.60%. The four week rolling average market share were at 5.47% (up 0.01 since last week). Monthly buprenorphine/naloxone unit sales shows a y/y growth rate of 8.1%. The monthly TRx shows a y/y growth rate of 5.1%.